NKGN

NKGen Biotech, Inc. Common Stock NKGN

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode NKGN WINT ELAB BCTXZ PTIX XRTX MLEC VRAX DRMA NCEL
6M -80.00 % -92.98 % -68.65 % -61.76 % -66.57 % -31.26 % -95.18 % -50.91 % 216.66 % -89.21 %
YTD -92.76 % -99.76 % -96.28 % -70.23 % -83.63 % -48.72 % -96.03 % -82.36 % 53.96 % -88.07 %
1Y -92.22 % -99.75 % -96.47 % -70.23 % -84.09 % -46.43 % -95.94 % -79.70 % 73.98 % -86.87 %
3Y -99.12 % -100.00 % -99.99 % -70.23 % -94.85 % -90.87 % -96.63 % -93.39 % -95.28 % -99.46 %
5Y -99.12 % -100.00 % -99.99 % -70.23 % -99.06 % -97.88 % -96.68 % -99.79 % -99.83 % -99.78 %
10Y -99.12 % -100.00 % -99.99 % -70.23 % -99.06 % -97.88 % -96.68 % -99.79 % -99.83 % -99.78 %
Depuis le début -99.12 % -100.00 % -99.99 % -70.23 % -99.06 % -97.88 % -96.68 % -99.79 % -99.83 % -99.78 %

Dividende

Protagenic Therapeutics, Inc.

XORTX Therapeutics Inc.